Ascendis Pharma A/S (ASND) vs Halozyme Therapeutics, Inc. (HALO)

Ascendis Pharma A/S and Halozyme Therapeutics, Inc. are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $15.7B against $13.1B — 1.2× the size. Ascendis Pharma A/S trades at the lower P/E: 16.3× against 32.4×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 41.2%. Ascendis Pharma A/S has the higher net margin (71.2% vs 24.9%) and the lower return on invested capital (15.1% vs 18.1%). Across the 22 metrics below, Ascendis Pharma A/S leads on 12 and Halozyme Therapeutics, Inc. on 10.